HTG Molecular Diagnostics DSO Ratio 2011-2026 | HTGM

Annual DSO Ratio HTG Molecular Diagnostics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
101	75.4	67.8	60.1	85.1	157	98	64.7	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
157	60.1	88.6

Quarterly DSO Ratio HTG Molecular Diagnostics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	81	61.4	109	-	60.2	58.8	90.2	-	81.6	73.8	97.4	-	53.4	49.8	116	-	97.2	93.1	125	-	156	329	257	-	138	66.3	110	-	64.7	82.7	67.6	-	84	219	44.2	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
329	44.2	106

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Agilent Technologies A	63.8	$ 120.75	1.47 %	$ 36.7 B	USA
Anixa Biosciences ANIX	275	$ 2.94	3.71 %	$ 95.4 K	USA
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Aspira Women's Health AWH	50.7	-	-6.19 %	$ 10.5 M	USA
Burning Rock Biotech Limited BNR	31.7	$ 22.99	-2.36 %	$ 241 M	China
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Castle Biosciences CSTL	49.2	$ 28.42	3.08 %	$ 789 M	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
Charles River Laboratories International CRL	65	$ 179.43	2.05 %	$ 8.89 B	USA
Fulgent Genetics FLGT	77.4	$ 14.13	2.47 %	$ 427 M	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Biodesix BDSX	41.7	$ 15.23	-1.74 %	$ 1.97 B	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
IDEXX Laboratories IDXX	43.5	$ 644.54	1.42 %	$ 51.8 B	USA
Illumina ILMN	61.3	$ 130.66	0.85 %	$ 20.8 B	USA
BioNano Genomics BNGO	83.4	$ 1.15	2.23 %	$ 1.46 M	USA
Quest Diagnostics Incorporated DGX	44.9	$ 208.68	0.16 %	$ 23.2 B	USA
Danaher Corporation DHR	55.3	$ 204.89	0.41 %	$ 146 B	USA
Organovo Holdings ONVO	79.8	-	-2.3 %	$ 19.4 M	USA
Exact Sciences Corporation EXAS	30.8	$ 103.52	0.15 %	$ 19.5 B	USA
Bioventus BVS	92.3	$ 8.58	-1.83 %	$ 538 M	USA
DarioHealth Corp. DRIO	85.8	$ 9.4	-8.74 %	$ 267 M	Israel
DexCom DXCM	87	$ 73.32	0.33 %	$ 28.6 B	USA
PerkinElmer PKI	92.2	-	-0.91 %	$ 14.7 B	USA
Psychemedics Corporation PMD	61.3	-	-1.84 %	$ 15.3 M	USA
Precipio PRPO	28.1	$ 26.81	7.33 %	$ 34.8 M	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Quotient Limited QTNT	45.1	-	-11.32 %	$ 1.1 M	Schweiz
ICON Public Limited Company ICLR	68.5	$ 110.08	1.27 %	$ 9.08 B	Irlanda
Renalytix AI plc RNLX	15.9	-	5.66 %	$ 22.7 M	Britain
CareDx, Inc CDNA	51.5	$ 19.31	2.71 %	$ 1.03 B	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	52.9	$ 281.98	-0.38 %	$ 23.5 B	USA
Lantheus Holdings LNTH	80.5	$ 77.77	-1.36 %	$ 5.25 B	USA
Guardant Health GH	46.1	$ 94.48	1.26 %	$ 11.8 B	USA
IQVIA Holdings IQV	73.9	$ 176.07	1.19 %	$ 30.3 B	USA
Co-Diagnostics CODX	101	-	-	$ 79.8 M	USA
Mettler-Toledo International MTD	66.4	$ 1 303.14	-0.98 %	$ 26.9 B	Schweiz